About RaphAI
Company background
RaphAI Health Technologies Ltd is a Hong Kong-based company. Our strategic priority is to enable HKSAR both public & private MSK care sectors to be the most AI-adopted market and be the hub for ASEAN market expansion via collaboration with the local market Third-Party-Administrator (TPA) network.
Raphai Health Technologies is proud to become the member of the Hong Kong Science and Technology Park (HKSTP) in 2023 and spearhead AI-based health tech development along with other top health tech talent in Hong Kong SAR.
Know more about HKSTP
Our beliefs
We believe Asian MSK markets need an innovative disruption. The current MSK caregiver vs. total population ratio in China and ASEAN markets is more than 10 times lower than those in the US & EU markets. With the ageing population trend, most Asian markets, including China are facing a steep challenge in improving the existing MSK care system efficiency. In ASEAN markets, there is a fast growing organic demand for more advanced MSK care services with a rising population and GDP per capita.
We believe the existing physical clinic visit-only patient journey and model is not a long-term sustainable way to meet the sharp growing demand.
We believe Asian people deserve more affordable, easily accessible professional MSK care to help with their pain management.
We believe our technology can disrupt and help more Asians be relieved from pain.
